Teacher Retirement System of Texas Has $47.49 Million Position in Colgate-Palmolive (NYSE:CL)

Teacher Retirement System of Texas lessened its holdings in Colgate-Palmolive (NYSE:CL – Get Rating) by 14.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 626,327 shares of the company’s stock after selling 103,365 shares during the quarter. Teacher Retirement System of Texas’ holdings in Colgate-Palmolive were worth $47,494,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of CL. Centaurus Financial Inc. lifted its stake in shares of Colgate-Palmolive by 9.3% in the 4th quarter. Centaurus Financial Inc. now owns 4,199 shares of the company’s stock valued at $358,000 after acquiring an additional 357 shares during the last quarter. FDx Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 93.8% in the 4th quarter. FDx Advisors Inc. now owns 12,160 shares of the company’s stock valued at $1,038,000 after acquiring an additional 5,886 shares during the last quarter. AGF Investments Inc. bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at $249,000. Fifth Third Bancorp lifted its stake in shares of Colgate-Palmolive by 1.0% in the 4th quarter. Fifth Third Bancorp now owns 120,100 shares of the company’s stock valued at $10,249,000 after acquiring an additional 1,144 shares during the last quarter. Finally, RFG Advisory LLC lifted its stake in shares of Colgate-Palmolive by 12.3% in the 4th quarter. RFG Advisory LLC now owns 5,343 shares of the company’s stock valued at $456,000 after acquiring an additional 586 shares during the last quarter. Institutional investors and hedge funds own 78.12% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on CL shares. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Tuesday. Wells Fargo & Company raised Colgate-Palmolive from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $71.00 to $80.00 in a research report on Monday, August 1st. Barclays raised their target price on Colgate-Palmolive from $71.00 to $74.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Atlantic Securities lowered Colgate-Palmolive from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $92.00 to $80.00 in a research report on Tuesday, May 3rd. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Twelve investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $84.57.

Insider Transactions at Colgate-Palmolive

In related news, insider John W. Kooyman sold 19,683 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total value of $1,544,918.67. Following the sale, the insider now owns 7,007 shares of the company’s stock, valued at approximately $549,979.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider John W. Kooyman sold 19,683 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total value of $1,544,918.67. Following the sale, the insider now owns 7,007 shares of the company’s stock, valued at approximately $549,979.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $79.34, for a total transaction of $3,967,000.00. Following the completion of the sale, the chief executive officer now directly owns 221,790 shares in the company, valued at approximately $17,596,818.60. The disclosure for this sale can be found here. Insiders have sold 79,683 shares of company stock worth $6,297,119 in the last 90 days. Insiders own 0.32% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $80.43 on Friday. The company has a debt-to-equity ratio of 14.26, a current ratio of 1.17 and a quick ratio of 0.72. The stock has a 50-day moving average of $78.37 and a 200-day moving average of $78.33. The company has a market cap of $67.09 billion, a PE ratio of 34.82, a P/E/G ratio of 5.79 and a beta of 0.48. Colgate-Palmolive has a one year low of $72.20 and a one year high of $85.61.

Colgate-Palmolive (NYSE:CL – Get Rating) last issued its earnings results on Friday, July 29th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The company had revenue of $4.48 billion during the quarter, compared to the consensus estimate of $4.35 billion. Colgate-Palmolive had a return on equity of 315.10% and a net margin of 10.98%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the business posted $0.80 EPS. On average, equities research analysts predict that Colgate-Palmolive will post 3.03 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Thursday, July 21st will be paid a $0.47 dividend. The ex-dividend date is Wednesday, July 20th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.34%. Colgate-Palmolive’s payout ratio is presently 81.39%.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.